VentriPoint Diagnostics (TSE:VPT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
VentriPoint Diagnostics Ltd. has announced an expanded collaboration with ASCEND Cardiovascular to develop innovative AI-based cardiovascular solutions, aiming to enhance diagnostic accuracy and patient care. The partnership combines VentriPoint’s advanced imaging technology with ASCEND’s extensive experience and IT solutions in cardiology, with plans to integrate these technologies into clinical workflows and broaden their market reach.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.